Novartis Investigative Site

Ostend 8400

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Ovarian Cancer

Studies at this site

• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed